Therapeutic Area Research Reports

The global central nervous system therapeutic market was prized by USD 116.2 billion in 2020. It is estimated to witness 7.4% CAGR from 2021 to 2028. The progressions in diagnostics as well as therapeutics of central nervous system (CNS) illnesses are anticipated to globally augment the treatment speed. The rising frequency of central nervous system complaints in addition to the growing demand for effectual therapeutics alternatives are the factors, likely to increase enlargement of the market, for the duration of forecast.Read More »

The global hemophilia market size was accounted for USD 11.8 billion in 2019. It is also estimated to witness 5.5% CAGR over the forecasted period, 2020 to 2027. An increase in the R&D spending for the identification of therapeutic agents is projected to drive the market growth across the globe.Read More »

The global CBD pet market size was accounted for USD 27.7 million in 2019. It is also projected to witness 40.3% CAGR over the forecasted period, 2020 to 2027. Rising awareness about the consumption of cannabis prevailing among pet owners and shifting trend towards natural pet supplements is expected to drive the market growth.Read More »

Global Insomnia Therapeutics Market is anticipated to reach USD 3.45 billion by 2025. Insomnia Therapy implies different patterns of treatment to address trouble with respect to initiation as well as maintenance of sleep. These sleep disorders are termed as “Insomnia”. Insomnia results in non-productive work hours. If left untreated, this condition may lead to a nervous breakdown and/or depression in the patient.Read More »